Quaak M - Search Results

1

Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma.

Klaassen EM, van de Kant KD, Jöbsis Q, Penders J, van Schooten FJ, Quaak M, den Hartog GJ, Koppelman GH, van Schayck CP, van Eys G, Dompeling E. Klaassen EM, et al. Among authors: quaak m. Pediatr Allergy Immunol. 2014 Mar;25(2):166-72. doi: 10.1111/pai.12187. Epub 2014 Jan 6. Pediatr Allergy Immunol. 2014. PMID: 24393359

2

Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ. Quaak M, et al. Eur Respir J. 2009 Mar;33(3):468-80. doi: 10.1183/09031936.00056908. Eur Respir J. 2009. PMID: 19251795 Free article. Review.

3

Pharmacogenetics of smoking: how far to the clinic?

Quaak M, van Schooten FJ, van Schayck CP. Quaak M, et al. Pharmacogenomics. 2014 Apr;15(6):723-6. doi: 10.2217/pgs.14.34. Pharmacogenomics. 2014. PMID: 24897278 No abstract available.

4

CD14/Toll-like receptors interact with bacteria and regulatory T-cells in the development of childhood asthma.

Klaassen EM, van de Kant KD, Soeteman M, Damoiseaux J, van Eys G, Stobberingh EE, Stelma FF, Quaak M, van Schayck OC, Jöbsis Q, Dompeling E. Klaassen EM, et al. Among authors: quaak m. Eur Respir J. 2014 Sep;44(3):799-802. doi: 10.1183/09031936.00020314. Epub 2014 Jul 17. Eur Respir J. 2014. PMID: 25034561 Free article. No abstract available.

5

Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ. Quaak M, et al. Mutat Res. 2009 Jul 10;667(1-2):44-57. doi: 10.1016/j.mrfmmm.2008.10.015. Epub 2008 Nov 5. Mutat Res. 2009. PMID: 19028511 Review.

6

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ. Quaak M, et al. Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21. Addiction. 2012. PMID: 21658141 Clinical Trial.

7

Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach.

Smerecnik C, Quaak M, van Schayck CP, van Schooten FJ, de Vries H. Smerecnik C, et al. Among authors: quaak m. Psychol Health. 2011 Aug;26(8):1099-112. doi: 10.1080/08870446.2010.541909. Epub 2011 Jun 28. Psychol Health. 2011. PMID: 21678175

8

Knowledge, attitudes and preferences regarding genetic testing for smoking cessation. A cross-sectional survey among Dutch smokers.

Quaak M, Smerecnik C, van Schooten FJ, de Vries H, van Schayck CP. Quaak M, et al. BMJ Open. 2012 Jan 5;2(1):e000321. doi: 10.1136/bmjopen-2011-000321. Print 2012. BMJ Open. 2012. PMID: 22223839 Free PMC article.

9

[Pharmacogenetics in the treatment of tobacco addiction].

Quaak M, van Schooten FJ, van Schayck CP. Quaak M, et al. Tijdschr Psychiatr. 2013;55(11):891-8. Tijdschr Psychiatr. 2013. PMID: 24242150 Free article. Review. Dutch.

10

Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis.

Smerecnik C, Grispen JE, Quaak M. Smerecnik C, et al. Among authors: quaak m. Tob Control. 2012 May;21(3):347-54. doi: 10.1136/tc.2011.042739. Epub 2011 Sep 26. Tob Control. 2012. PMID: 21948804 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters